1. Home
  2. IMNN vs RMCF Comparison

IMNN vs RMCF Comparison

Compare IMNN & RMCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • RMCF
  • Stock Information
  • Founded
  • IMNN 1982
  • RMCF 1981
  • Country
  • IMNN United States
  • RMCF United States
  • Employees
  • IMNN N/A
  • RMCF N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • RMCF Specialty Foods
  • Sector
  • IMNN Health Care
  • RMCF Consumer Staples
  • Exchange
  • IMNN Nasdaq
  • RMCF Nasdaq
  • Market Cap
  • IMNN 12.9M
  • RMCF 11.4M
  • IPO Year
  • IMNN 1985
  • RMCF N/A
  • Fundamental
  • Price
  • IMNN $5.10
  • RMCF $1.57
  • Analyst Decision
  • IMNN Buy
  • RMCF
  • Analyst Count
  • IMNN 2
  • RMCF 0
  • Target Price
  • IMNN $182.61
  • RMCF N/A
  • AVG Volume (30 Days)
  • IMNN 160.1K
  • RMCF 762.1K
  • Earning Date
  • IMNN 11-06-2025
  • RMCF 10-13-2025
  • Dividend Yield
  • IMNN N/A
  • RMCF N/A
  • EPS Growth
  • IMNN N/A
  • RMCF N/A
  • EPS
  • IMNN N/A
  • RMCF N/A
  • Revenue
  • IMNN N/A
  • RMCF $29,988,000.00
  • Revenue This Year
  • IMNN N/A
  • RMCF N/A
  • Revenue Next Year
  • IMNN N/A
  • RMCF N/A
  • P/E Ratio
  • IMNN N/A
  • RMCF N/A
  • Revenue Growth
  • IMNN N/A
  • RMCF 8.09
  • 52 Week Low
  • IMNN $4.70
  • RMCF $1.12
  • 52 Week High
  • IMNN $41.22
  • RMCF $3.49
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 41.04
  • RMCF 46.67
  • Support Level
  • IMNN $4.91
  • RMCF $1.61
  • Resistance Level
  • IMNN $5.39
  • RMCF $1.75
  • Average True Range (ATR)
  • IMNN 0.24
  • RMCF 0.12
  • MACD
  • IMNN 0.00
  • RMCF -0.01
  • Stochastic Oscillator
  • IMNN 26.51
  • RMCF 22.22

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About RMCF Rocky Mountain Chocolate Factory Inc.

Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.

Share on Social Networks: